Innoviva Specialty Therapeutics’ Antimicrobial Therapies, XACDURO®, ZEVTERA® and NUZOLVENCE® Designated Finalists for the 2026 Prix Galien USA Best Pharmaceutical Product Award
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq climbs over 1% as SpaceX, Super Micro improve AI sentiment
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Nvidia’s Huang highlights AI benefits in Berlin speech amid wider European tour
- AI bubble about to burst? Not yet, Yardeni says
| Inova Technology, Inc. (NASDAQ: INVA) | Delayed: 21.06 -0.22 (1.03%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $21.28 | 52 Week High | $14.15 | |||
| Open | $21.20 | 52 Week Low | $7.56 | |||
| Day High | $21.36 | P/E | N/A | |||
| Day Low | $20.96 | EPS | $0.00 | |||
| Volume | 103,981 | |||||
